Performance of microscopic observation drug susceptibility for the rapid diagnosis of tuberculosis and detection of drug resistance in Bamako, Mali
- 1 June 2017
- journal article
- research article
- Published by Elsevier in Clinical Microbiology and Infection
- Vol. 23 (6) , 408.e1-408.e6
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Allergy and Infectious Diseases (AI069471, AI110386, TW010350)
- National Cancer Institute, National Institutes of Health (HHSN261200800001E)
This publication has 17 references indexed in Scilit:
- Evaluation of the microscopic observation drug susceptibility assay for the rapid detection of MDR-TB and XDR-TB in China: a prospective multicentre studyJournal of Antimicrobial Chemotherapy, 2014
- A Field Evaluation of the Hardy TB MODS Kit™ for the Rapid Phenotypic Diagnosis of Tuberculosis and Multi-Drug Resistant TuberculosisPLOS ONE, 2014
- Evaluation of the microscopic observational drug susceptibility assay for rapid and efficient diagnosis of multi-drug resistant tuberculosisIndian Journal of Medical Microbiology, 2012
- Evaluation of microscopic observation drug susceptibility assay for diagnosis of multidrug-resistant Tuberculosis in Viet NamBMC Infectious Diseases, 2012
- MDR Tuberculosis — Critical Steps for Prevention and ControlNew England Journal of Medicine, 2010
- Tuberculosis Diagnosis — Time for a Game ChangeNew England Journal of Medicine, 2010
- Rapid Molecular Detection of Tuberculosis and Rifampin ResistanceNew England Journal of Medicine, 2010
- Multidrug-resistant and extensively drug-resistant tuberculosis: a reviewCurrent Opinion in Infectious Diseases, 2008
- Microscopic-Observation Drug-Susceptibility Assay for the Diagnosis of TBNew England Journal of Medicine, 2006
- Fluorescence versus conventional sputum smear microscopy for tuberculosis: a systematic reviewThe Lancet Infectious Diseases, 2006